CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) saw a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 1,339 shares, a decrease of 54.3% from the September 30th total of 2,927 shares. Based on an average daily trading volume, of 4,208 shares, the days-to-cover ratio is currently 0.3 days.
CSPC Pharmaceutical Group Stock Performance
CSPCY remained flat at C$4.11 during midday trading on Friday. The company’s stock had a trading volume of 699 shares, compared to its average volume of 2,962. CSPC Pharmaceutical Group has a 12 month low of C$3.26 and a 12 month high of C$5.46. The business has a fifty day moving average of C$4.63 and a 200 day moving average of C$4.45.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. The company researches, develops, manufactures and distributes finished pharmaceutical products and active pharmaceutical ingredients, serving hospitals, pharmacies and other healthcare channels.
Its product portfolio includes medicines for neurological, cardiovascular, oncology, anti-infective and other therapeutic areas. CSPC is known for products such as butylphthalide, used in the treatment of ischemic stroke, as well as oncology medicines, injectable therapies and a range of generic drugs.
Further Reading
- Five stocks we like better than CSPC Pharmaceutical Group
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
